Discover
KNSA
Kiniksa Pharmaceuticals International, plc
77.73
1 x 77.73
1 x 77.85
bid
ask
+
1.20
1.57%
01:40 PM
timesize
| Ytd | 88.44% | |
| 1y | 137.42% |
75.72
day range
78.25
32.06
52 week range
82.94
| Open | 76.67 | Prev Close | 76.53 | Low | 75.72 | High | 78.25 | Mkt Cap | 5.92B |
| Vol | 167.44K | Avg Vol | 759.44K | EPS | 0.90 | P/E | 86.36 | Forward P/E | 47.02 |
| Beta | 0.05 | Short Ratio | 4.34 | Inst. Own | 104.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-28 | 50-d Avg | 61.60 | 200-d Avg | 49.10 | 1yr Est | 98.00 |
| Income Statement | |||
| Total Revenue | 243.60M | ||
| Revenues (USD) | 243.60M | ||
| Cost of Revenue | 23.57M | ||
| Gross Profit | 220.03M | ||
| Operating Expenses | 192.83M | ||
| Research and Development Expense | 40.90M | ||
| Selling, General and Administrative Expense | 63.87M | ||
| Operating Income | 27.19M | ||
| Income Tax Expense | 5.71M | ||
| Net Income | 25.43M | ||
| Net Income Common Stock | 25.43M | ||
| Net Income Common Stock (USD) | 25.43M | ||
| Consolidated Income | 25.43M | ||
| Earnings per Basic Share | 0.33 | ||
| Earnings per Basic Share (USD) | 0.33 | ||
| Earnings per Diluted Share | 0.30 | ||
| Earning Before Interest & Taxes (EBIT) | 31.15M | ||
| Earning Before Interest & Taxes (USD) | 31.15M | ||
| Weighted Average Shares | 77.58M | ||
| Weighted Average Shares Diluted | 83.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 175.68M | ||
| Cash and Equivalents (USD) | 175.68M | ||
| Investments | 350.25M | ||
| Investments Current | 350.25M | ||
| Trade and Non-Trade Receivables | 23.49M | ||
| Current Assets | 668.63M | ||
| Property, Plant & Equipment Net | 10.93M | ||
| Total Assets | 896.11M | ||
| Debt Current | 4.01M | ||
| Total Debt | 8.90M | ||
| Current Liabilities | 171.25M | ||
| Debt Non-Current | 4.89M | ||
| Total Liabilities | 241.96M | ||
| Accumulated Retained Earnings (Deficit) | -414.11M | ||
| Accumulated Other Comprehensive Income | -1.38M | ||
| Shareholders Equity | 654.15M | ||
| Shareholders Equity (USD) | 654.15M | ||
| Assets Non-Current | 227.48M | ||
| Total Debt (USD) | 8.90M | ||
| Deferred Revenue | 31.81M | ||
| Goodwill and Intangible Assets | 14.75M | ||
| Inventory | 70.93M | ||
| Liabilities Non-Current | 70.71M | ||
| Trade and Non-Trade Payables | 12.40M | ||
| Tax Assets | 190.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.48M | ||
| Net Cash Flow from Financing | 12.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -14.27M | ||
| Capital Expenditure | -663.00K | ||
| Issuance (Purchase) of Equity Shares | 12.11M | ||
| Net Cash Flow from Investing | -73.58M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -72.92M | ||
| Net Cash Flow from Operations | 47.20M | ||
| Share Based Compensation | 11.64M | ||